EUVIMEDEUVIMED entdecken
Crossref

Mesoporous polydopamine-based biomimetic nanoplatform for immunotherapy of multiple myeloma by homologous targeting and systemic immune activation

Yonghua Li, Yang Gao, Zhifang Xiao, Wenfang Jiang, Na Han, Xianjun He, Ling Ouyang, Peng Zhang

Biomaterials Advances · 2026-08 · 185 · 214853

DOI: 10.1016/j.bioadv.2026.214853 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Advances, 2026-08. Verfasst von Yonghua Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou University of Chinese Medicine, Guangzhou, 510010, Guangdong, China; Department of Hematology, General Hospital of Southern Theater Command…. Hauptthemen laut MEDLINE: Indoles, Polymers, Multiple Myeloma, Immunotherapy. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Bureau, Guangzhou Municipal Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photothermal therapy (PTT) not only directly eliminates tumors through its photothermal effects but also triggers a critical antitumor immune response. This study created a multifunctional nanoplatform out of biodegradable mesoporous polydopamine (mPDA). By doping manganese ions (Mn2+) to generate mPDA@Mn nanoparticles, the material's photothermal conversion efficiency was greatly improved, as was the efficient loading of the anticancer medication carfilzomib. This system enables precise control over the release of CFZ and Mn2+ under near-infrared (NIR) irradiation, achieving triple synergistic antitumor effects through chemotherapy, photothermal therapy, and immune activation at the tumor site. In vitro experiments demonstrated that the cell membrane-coated CM@mPDA@Mn/CFZ nanosystem exhibits favorable biocompatibility. In a mouse model of multiple myeloma, the combination of this nanosystem with NIR irradiation showed significant synergistic therapeutic efficacy. It not only destroyed tumor cells directly, but it also stimulated dendritic cell (DC) maturation, CD3+ T cell activation, and cytotoxic T lymphocyte (CTL) infiltration, substantially modifying the tumor immune microenvironment. These findings suggest that this triple synergistic method, which combines chemotherapy, photothermal ablation, and immune activation, provides an effective and targeted nanotherapeutic platform for the treatment of multiple myeloma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndolesPolymersMultiple MyelomaImmunotherapyNanoparticlesBiomimetic MaterialsAnimalsMicePorosityHumansCell Line, TumorPhotothermal TherapyDendritic CellsAntineoplastic AgentsFemale

Stichwörter der Autor:innen

Cancer immunotherapyMesoporous polydopamineMultiple myelomaNanoplatformPhotothermal therapy

Substanzen

polydopamineIndolesPolymersAntineoplastic Agents

Autor:innen und Institutionen

  • Guangzhou University of Chinese Medicine, Guangzhou, 510010, Guangdong, China; Department of Hematology, General Hospital of Southern Theater Command, Guangzhou, 510010, Guangdong, China; The First School of Clinical Me…
  • Department of Hematology, General Hospital of Southern Theater Command, Guangzhou, 510010, Guangdong, China.
  • Department of Hematology, General Hospital of Southern Theater Command, Guangzhou, 510010, Guangdong, China; The First School of Clinical Medicine, Southern Medical University, Guangzhou, 510010, Guangdong, China.

Förderung

  • Guangzhou Municipal Science and Technology Bureau
  • Guangzhou Municipal Science and Technology Project

Zitieren

APA

Li, Y., Gao, Y., Xiao, Z., Jiang, W., Han, N., He, X., Ouyang, L., & Zhang, P. (2026). Mesoporous polydopamine-based biomimetic nanoplatform for immunotherapy of multiple myeloma by homologous targeting and systemic immune activation. Biomaterials Advances, 185, 214853. https://doi.org/10.1016/j.bioadv.2026.214853

Vancouver

Li Y, Gao Y, Xiao Z, Jiang W, Han N, He X, et al. Mesoporous polydopamine-based biomimetic nanoplatform for immunotherapy of multiple myeloma by homologous targeting and systemic immune activation. Biomaterials Advances. 2026;185:214853. doi:10.1016/j.bioadv.2026.214853

BibTeX
@article{Li2026,
  author = {Li, Yonghua and Gao, Yang and Xiao, Zhifang and Jiang, Wenfang and Han, Na and He, Xianjun and Ouyang, Ling and Zhang, Peng},
  title = {Mesoporous polydopamine-based biomimetic nanoplatform for immunotherapy of multiple myeloma by homologous targeting and systemic immune activation},
  journal = {Biomaterials Advances},
  year = {2026},
  volume = {185},
  pages = {214853},
  doi = {10.1016/j.bioadv.2026.214853}
}
Kostenlos starten →